Skip to main content
. 2022 Sep 7;22:531. doi: 10.1186/s12887-022-03556-z

fig. 1.

fig. 1

Flow chart of patients enrolled in the SPECS trial.

ND Neurodevelopmental, SPECS Safe pediatric euglycemia after cardiac surgery, STD Standard care, TGC Tight glycemic control. 872 patients were eligible for 3-year-old follow-up, 269 had any follow-up between 30–42.5 months of age, and 214 had in-person testing. a 221 patients (97 TGC, 124 STD) without genetic anomaly. b 169 patients (72 TGC, 97 STD) without genetic anomaly